These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2189345)
1. Tumour markers--a diagnostic and therapeutic perspective. Aw SE; Sundram FX Ann Acad Med Singap; 1990 Mar; 19(2):244-50. PubMed ID: 2189345 [TBL] [Abstract][Full Text] [Related]
2. [Tumor markers]. Fiebiger W; Wiltschke C Acta Med Austriaca; 2001; 28(2):33-7. PubMed ID: 11382139 [TBL] [Abstract][Full Text] [Related]
3. Tumour markers in oncology: past, present and future. Magdelénat H J Immunol Methods; 1992 Jun; 150(1-2):133-43. PubMed ID: 1613250 [TBL] [Abstract][Full Text] [Related]
4. [Future prospects for the use of tumor markers]. Grunicke H Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607 [TBL] [Abstract][Full Text] [Related]
6. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected]. Sundararajan V; Sarkar FH; Ramasamy TS Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069 [TBL] [Abstract][Full Text] [Related]
7. Use of tumour markers in cancer diagnosis and treatment. Higgins C Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591 [TBL] [Abstract][Full Text] [Related]
8. Can molecular markers now be used for early diagnosis of malignancy? Duffy MJ Clin Chem; 1995 Oct; 41(10):1410-3. PubMed ID: 7586509 [TBL] [Abstract][Full Text] [Related]
9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
10. Biting the magic bullet. Radiolabelled monoclonal antibodies: the next great step forward in the diagnosis and treatment of cancer? Persaud RD Med Hypotheses; 1988 Nov; 27(3):245-51. PubMed ID: 3062339 [TBL] [Abstract][Full Text] [Related]
11. A review of the role of established tumour markers. Beastall GH; Cook B; Rustin GJ; Jennings J Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():5-18. PubMed ID: 2024935 [TBL] [Abstract][Full Text] [Related]
12. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Kontos CK; Scorilas A Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268 [TBL] [Abstract][Full Text] [Related]
13. Oncogenes as markers for early detection of cancer. Cooper GM J Cell Biochem Suppl; 1992; 16G():131-6. PubMed ID: 1469892 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in human cancer: from research to therapy. Negrini M; Ferracin M; Sabbioni S; Croce CM J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481 [TBL] [Abstract][Full Text] [Related]
15. RATIONAL USE OF SERUM TUMOUR MARKERS IN DIAGNOSTICS AND TREATMENT OF SOLID TUMOURS. Plavetić ND; Gnjidić M; Kulić A; Ivić M; Kukec I; Vidović M Lijec Vjesn; 2016; 138(3-4):85-92. PubMed ID: 30146854 [TBL] [Abstract][Full Text] [Related]
16. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Mansoori B; Mohammadi A; Shirjang S; Baradaran B Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381 [TBL] [Abstract][Full Text] [Related]